Last update :
28/04/2024
Anticancer drug   Atezolizumab  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Tecentriq Argentina, Austria, Belgium, Brazil, Chile, France, Germany, Great Britain, Italy, Mexico, Netherlands, Peru, Spain, Switzerland
References   Injection   References : Atezolizumab  
Type Publication
2296 Manufacturer Témocilline (Negaban®) - Résumé des caractéristiques du produit
Eumedica 2017
4532 Manufacturer Atezolizumab (Tecentriq®) - Summary of Product Characteristics
Roche Products Limited 2021
4583 Journal Hui A, Yin J, Liu W, Zheng K.
Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags
Int J Pharm Compound 2021 ;25,3:246-257

  Mentions Légales